CervoMed Inc.

CRVO Nasdaq SEC CIK 1053691
Follow CervoMed Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $0 −100% vs same quarter last year
Net income −$5.9M +23.7% vs same quarter last year
EPS, diluted −$0.39 +53.6% vs same quarter last year
Operating cash flow −$5.1M +21.5% vs same quarter last year
Revenue by quarter
$2.2M
$1.9M
$1.8M
$322.6K
$8.7K
$0
$0
$0
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$30M−$20M−$10M$0$10MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$4M−$27M
FY24$9.7M−$16.3M
FY23$7.1M−$2.2M
FY22$0-
FY21--
FY20--
FY19--
FY18--
FY17-−$1.4M
FY16-−$18M
FY15-−$6.7M
FY14-−$14.4M
FY13$71.7K−$2.5M
FY12$374.5K−$6.9M
FY11$570.5K−$22.6M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20000%−15000%−10000%−5000%0%5000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25-−706.2%−673.2%
FY24-−187.2%−167.3%
FY23-−109.3%−30.4%
FY22---
FY21---
FY20---
FY19---
FY18---
FY17---
FY16---
FY15---
FY14---
FY13100%−17855.5%−3429.7%
FY1237%−3148.3%−1833.9%
FY11−304.7%−2879.9%−3967.9%
Free cash flowOperating cash flow minus capital expenditure
−$15M−$10M−$5M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24-
FY23-
FY22-
FY21-
FY20-
FY19-
FY18-
FY17−$12.8M
FY16−$10.8M
FY15−$5.2M
FY14−$9.1M
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • CervoMed
  • Healthcare median
−4000%−3000%−2000%−1000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearCervoMedHealthcare median
FY25−673.2%−30.6%
FY24−167.3%−47%
FY23−30.4%−58%
FY22-−80.4%
FY21-−71.9%
FY20-−62.2%
FY19-−46.3%
FY18-−49.6%
FY17-−45.9%
FY16-−36%
FY15-−38.4%
FY14-−35.5%
FY13−3429.7%−37.1%
FY12−1833.9%−29.1%
FY11−3967.9%−27.9%